News | January 7, 2020

Principia Announces Expanded Development Program to Broaden BTK Footprint in Immune-Mediated Diseases Company’s lead candidate PRN1008 receives generic name — rilzabrutinib Rilzabrutinib to enter clinical trial in IgG4-Related Disease SOUTH SAN FRANCISCO,...

News | December 31, 2019

Principia Updates PRN1008 Pemphigus Clinical Program Accelerated enrollment of company’s Phase 3 pivotal trial anticipating final results in second half of 2021 SOUTH SAN FRANCISCO, Calif., Dec. 30, 2019 (GLOBE NEWSWIRE) — Principia Biopharma Inc. (Nasdaq:...

News | December 16, 2019

Kit Check’s Bluesight for Controlled Substances Solution Implemented at 10 OhioHealth Hospitals Rapid cloud-based implementation for nationally recognized health system committed to addressing drug diversion and the opioid crisis already yielding results WASHINGTON...

News | December 9, 2019

Omnicell and Kit Check Partner to Offer Cloud-based Solution for Tracking of Controlled Substances Medication intelligence software solution supports critical need for hospitals and health systems to identify drug diversion to combat national opioid crisis MOUNTAIN...

News | December 6, 2019

MPI Label Systems Partners With Kit Check To Provide Custom RFID Tags for Medication Inventory Tracking Label leader engineers top RFID tags for pharmaceuticals, follows FDA guidelines for best labeling practice WASHINGTON (December 06, 2019) – Kit Check, the leader...